Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101362752B details a safer synthesis of Lamivudine intermediates using Triphosgene, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN118255768A details high-purity Ruxolitinib synthesis via chiral resolution. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN115368317A details a novel salting-out method for 1-(2,3-dichlorophenyl)piperazine hydrochloride, ensuring low dimer impurities and reduced solvent usage.
Advanced synthesis patent CN105859643B offers high-purity intermediates with streamlined processes for reduced costs and reliable supply chain continuity.
Patent CN101792414A details a green Heck reaction for 2-(3'-quinolyl) allyl alcohol using ionic liquids, offering cost reduction and scalable pharmaceutical intermediate manufacturing.
Novel salt-formation purification method for Letrozole eliminates isomers without chromatography, ensuring high purity and cost-effective manufacturing for global supply chains.
Patent CN103951588A reveals a novel chiral squaramide catalytic route for saxagliptin intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN104045589B reveals water-phase copper catalysis for aryl alkyl sulfides. Offers cost reduction and scalable manufacturing for pharma intermediates.
Patent CN111333526B reveals a green photoredox method for N-aryl glycine esters. Discover cost-effective, scalable synthesis for pharmaceutical intermediates.
Novel one-step nucleophilic substitution method for high-purity amlodipine. Reduces impurities and manufacturing costs for reliable supply chain partners.
Patent CN110305128B reveals a novel TfOH-catalyzed cyclization route for 5-aminobenzo[b][1,8]naphthyridines. Offers high yields and scalable manufacturing for antitumor drug development.
Novel patent CN114478407B enables solid-state purification of chiral homopiperazine. Reduces costs and enhances supply chain reliability for pharmaceutical manufacturing.
Patent CN110511214A reveals a ruthenium-catalyzed route for diamine heterocycles, offering cost reduction and scalable supply for antitumor pharmaceutical intermediates.
Patent CN103275108B details a one-step chiral copper complex synthesis offering simplified manufacturing and potential cost reduction for pharmaceutical intermediate supply chains.
Patent CN109265408B details a safe 2-step synthesis replacing hazardous 9-step routes, offering high-purity pharmaceutical intermediates with reduced costs.
Patent CN103772229A details a green Cu2O-catalyzed oxidative amidation route. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104356069B reveals optimized Grignard route reducing impurities. Enables cost reduction in pharma intermediate manufacturing and reliable supply chain.
Discover the Rh-catalyzed asymmetric hydrogenation patent CN116444412A for chiral trifluoromethyl nitrogen heterocycles. Achieve high ee values and cost reduction in pharmaceutical intermediate manufacturing with scalable solutions.
Patent CN106632194B enables safer benzopyrone production using iron pentacarbonyl. Reduces equipment costs and improves supply chain reliability for pharmaceutical intermediates.
Novel patent CN118878537B details cost-effective synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.